If you have spent years knowing your condition as PCOS, you may have recently seen a completely different acronym appearing online: PMOS.

And understandably, you might be wondering:

Do I have something different now?

Does my diagnosis change?

Why have they changed a name we've used for decades?

And what exactly does “Polyendocrine Metabolic Ovarian Syndrome” even mean?

There is a lot to unpack, because this is much bigger than swapping one letter.

In May 2026, Polycystic Ovary Syndrome (PCOS) was officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) following an enormous international consensus process.

The condition itself hasn't suddenly changed.

What has changed is the language being used to describe it because after decades of research, the old name simply wasn't accurately representing the condition or the people living with it.

And for a condition affecting approximately 1 in 8 women worldwide, language matters.

First things first: what is PMOS?

PMOS stands for: Polyendocrine Metabolic Ovarian Syndrome.

It is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS).

It is not a newly discovered disease. It is not a new subtype of PCOS. And if you have already been diagnosed with PCOS, the change to PMOS does not mean that you suddenly need to be diagnosed with a different condition.

The international terminology changed because our understanding of the condition has evolved enormously since the name “polycystic ovary syndrome” was introduced.

PMOS is a complex, chronic condition involving interconnected hormonal, metabolic, ovarian, reproductive and psychological health factors. It can affect menstrual cycles and ovulation, but its effects can extend far beyond periods and fertility.

Why was PCOS renamed?

This conversation has actually been happening for a very long time. PCOS was named in the 1930s following observations of the appearance of ovaries during surgery. At the time, the ovarian appearance became central to the name. Nearly a century later, we know considerably more.

One of the biggest problems with “Polycystic Ovary Syndrome” is the word polycystic.

Despite what the old name suggests, PMOS is not simply a condition where someone has lots of abnormal ovarian cysts. The structures traditionally described as “cysts” are actually ovarian follicles associated with arrested follicular development.

And perhaps even more importantly: You do not have to have polycystic appearing ovaries to have PMOS.

That created an enormous opportunity for misunderstanding. Someone could hear “polycystic ovary syndrome” and reasonably assume: “No cysts on my ultrasound = I can't have PCOS.”

But that isn't how the condition works.

The old name also placed enormous emphasis on the ovaries when the condition can involve far more than ovarian or reproductive health.

Breaking down the new name:

The new terminology is designed to tell us considerably more about the condition.

POLYENDOCRINE:

“Poly” means multiple. “Endocrine” refers to the body's hormone producing system. Rather than suggesting that PMOS is solely an ovarian problem, polyendocrine recognises that multiple hormonal pathways and systems can be involved.

Androgens are particularly important in PMOS.

Higher androgen levels or clinical signs of androgen excess can contribute to symptoms including:

• Excess facial or body hair
• Acne and oily skin
• Scalp hair thinning or female-pattern hair loss
• Changes in ovulation and menstrual cycles

The word polyendocrine therefore shifts the conversation away from: “What's wrong with your ovaries?” towards: “What is happening across your hormonal system?” That distinction matters.

METABOLIC:

This might be one of the most important additions to the name. PMOS isn't exclusively a reproductive condition. It is also associated with metabolic health.

People living with PMOS can have increased risks of conditions or complications including insulin resistance, type 2 diabetes, abnormal cholesterol levels, high blood pressure and cardiovascular disease.

Importantly, metabolic health should not be reduced to someone's body size.

International guidelines recommend consideration and assessment of metabolic and cardiovascular risk factors in people with PMOS, and this matters regardless of assumptions made based on appearance alone.

Including metabolic directly in the name helps acknowledge an aspect of the condition that has historically been overlooked. PMOS deserves to be considered across a person's health and lifespan - not only when someone presents with irregular periods or wants to become pregnant.

OVARIAN:

The ovaries haven't disappeared from the name because ovarian function can still be an important part of PMOS. PMOS can affect follicular development, ovulation and menstrual cycles. Some people have a higher number of follicles visible on ultrasound, while others diagnosed with PMOS will not have this ovarian appearance. “Ovarian” therefore remains relevant. It simply isn't being treated as the entire story anymore.

SYNDROME:

A syndrome describes a collection of features that can occur together. And that is particularly relevant to PMOS because there isn't one universal PMOS experience. One Warrior may struggle predominantly with irregular periods and acne. Another may experience significant metabolic complications. Someone else may seek medical help because they're struggling to conceive. Another may experience hair growth, scalp hair loss or mental health impacts. Two people can have the same condition while experiencing it very differently. 

So, are the “cysts” actually cysts? This is one of the biggest misconceptions the name change is trying to correct.

The ovarian structures historically associated with PCOS are follicles, not the pathological ovarian cysts many people imagine when they hear the word “cyst.” Follicles are normal structures within ovaries containing developing eggs. People with PMOS can have an increased number of these follicles and disrupted follicular development.

But:

Having an ovarian cyst does not automatically mean you have PMOS.

And:

Not having “cysts” does not automatically mean you don't have PMOS.

This distinction alone demonstrates why “polycystic” was such a confusing word to have at the front of the condition's name. Does the name change alter how PMOS is diagnosed? This part is extremely important.

The May 2026 terminology change did not suddenly create a completely new disease or replace the existing evidence based diagnostic framework.

The updated international information specifically states that the recommendations and content of the current guideline remain unchanged following the terminology update.

In adults, diagnosis continues to consider three major features:

1. Ovulatory dysfunction: such as irregular, infrequent or absent menstrual cycles/ovulation.

2. Hyperandrogenism: clinical signs and/or biochemical evidence of higher androgen levels.

3. Polycystic ovarian morphology: identified through appropriate assessment.

Other possible causes of these features need to be excluded.

Generally, at least two of the three diagnostic features are required in adults.

Importantly, the 2023 International Evidence based Guideline also introduced Anti-Müllerian Hormone (AMH) as a possible alternative to ultrasound for defining polycystic ovarian morphology in adults within the diagnostic algorithm. It should not simply be used as a standalone test to diagnose PMOS.

Diagnosis in adolescents is different and requires particular caution because normal puberty can overlap with features associated with PMOS.

So please don't look at the new name and think:

“I was diagnosed with PCOS, so now I need to start the entire diagnostic process again.”

The terminology changed.

Your lived experience didn't.

What symptoms can PMOS cause?

PMOS can look different from person to person, but recognised features and associated concerns can include:

• Irregular, infrequent or absent periods
• Irregular or absent ovulation
• Difficulty conceiving
• Excess facial or body hair
• Acne or oily skin
• Scalp hair thinning or female pattern hair loss
• Higher androgen levels
• Insulin resistance and metabolic complications
• Changes in weight or difficulty with weight management
• Sleep apnoea
• Increased cardiovascular risk factors
• Pregnancy complications
• Anxiety
• Depression
• Eating disorders or disordered eating
• Body-image distress
• Reduced quality of life

Not everyone with PMOS will experience every one of these. And the severity of one person's symptoms cannot be used to judge another person's condition. PMOS is about more than fertility This is something we hope the new name helps change. For decades, conversations surrounding PCOS have often centred heavily on:

Periods. Ovaries. Pregnancy. Fertility. Those things absolutely matter.

But a Warrior's health doesn't suddenly become important only when they want to become pregnant.

PMOS is associated with longer-term metabolic, cardiovascular and psychological considerations that deserve appropriate attention too. International guidance recommends cardiovascular risk assessment, including a lipid profile at diagnosis, and ongoing blood pressure assessment.

Mental health also deserves to be part of the conversation.

PMOS has recognised associations with anxiety, depression, eating disorders, body-image concerns and reduced quality of life.

That means comprehensive PMOS care may involve far more than a gynaecologist alone.

Depending on the individual's needs, care may involve a GP, endocrinologist, gynaecologist, dietitian, dermatologist, fertility specialist, psychologist or other appropriately qualified health professionals.

Why does changing a name actually matter?

At first glance, PCOS → PMOS can look like one letter changing. But names influence how conditions are understood.

Imagine spending years experiencing irregular cycles, acne, hair changes, insulin resistance and other symptoms, only to be told:

“Your ovaries don't have cysts, so it probably isn't PCOS.”

Or being diagnosed and having the entire conversation revolve around whether you want children, while nobody discusses your metabolic or psychological health.

This is exactly why terminology can have real-world consequences.

The international name change project identified concerns associated with the old terminology including:

Scientific inaccuracy: The term “polycystic” implied pathological ovarian cysts that aren't actually the defining feature the name suggested.

Delayed or missed diagnosis: A narrow focus on ovarian appearance could contribute to misunderstanding and diagnostic delays.

Fragmented care: A predominantly reproductive framing could overlook metabolic, cardiovascular, dermatological and psychological aspects.

Stigma: For some people, a strongly reproductive or fertility focused condition name created additional distress and stigma.

Changing the terminology won't magically solve those problems overnight. But changing how we describe a condition can begin changing how we think about it. And ultimately, how we care for people living with it. This change took 14 years

PMOS wasn't a name somebody decided on during one meeting.

Calls to change the PCOS name have existed for years.

In 2012, a US National Institutes of Health evidence based workshop formally recommended that the name be changed.

The 2023 International Evidence based PCOS Guideline again recognised that the existing terminology was problematic. What followed was an enormous international effort.

The global consensus process behind PMOS involved 56 leading professional and patient organisations, healthcare professionals, researchers and people with lived experience. Across the broader engagement process, approximately 22,000 survey responses were received.

The formal published consensus research included responses from 14,360 people with PCOS and multidisciplinary healthcare professionals across world regions, alongside Delphi processes, workshops, nominal group techniques and implementation and branding analyses.

And importantly: People living with the condition helped drive the change.

The final terminology was selected based on principles including scientific accuracy, clarity, cultural appropriateness, minimising stigma and ensuring that the name could realistically be implemented internationally.

The consensus was: Polyendocrine Metabolic Ovarian Syndrome (PMOS).

Why keep “ovarian” in the name at all?

This was considered during the international process too.

No medical name is going to perfectly describe every biological pathway involved in such a complex syndrome. However, the final terminology needed to be scientifically meaningful while also being understandable, acceptable and practical enough to implement around the world.

“Polyendocrine Metabolic Ovarian Syndrome” was ultimately the preferred consensus name because it captures the endocrine, metabolic and ovarian dysfunction involved without continuing the inaccurate emphasis on “cysts.”

What happens to the term PCOS now?

You are going to see both terms for some time.

You may see:

PMOS

PMOS/PCOS

or:

Polyendocrine Metabolic Ovarian Syndrome (PMOS), formerly Polycystic Ovary Syndrome (PCOS).

That is intentional. The international strategy is designed around an evolution rather than an overnight transformation. The terminology was updated in May 2026, while the recommendations and clinical content of the current International Guideline remain unchanged.

The next International Evidence based Guideline, expected in 2028, is planned to incorporate PMOS as the standard terminology. In the meantime, medical records, websites, research papers, healthcare systems, educational resources and even individual healthcare professionals may transition at different speeds.

So don't panic if your doctor still says PCOS or your medical history still lists PCOS.

We are in a transition period.

Do I have to start calling myself a “PMOS Warrior”? No.

Medical terminology changing doesn't erase the relationship you may have developed with the words you've used for years. Some people will immediately embrace PMOS because they finally feel the name represents their condition more accurately. Others may feel strange about it. Some may continue saying PCOS for a while. Some may use both.

For someone who has spent 5, 10, 15 or 20+ years advocating for themselves under the PCOS name, it is completely understandable that changing terminology may take time.

There is no prize for switching acronyms fastest.

Education and transition matter more than policing people's language.

Does PMOS have a cure? There is currently no cure for PMOS.

Management is individualised and depends on someone's symptoms, priorities, life stage, metabolic health and whether pregnancy is currently desired. Management can include lifestyle support, medications to manage menstrual cycles or androgen related symptoms, treatments addressing metabolic health, psychological support and fertility treatment where required.

The important word here is individualised. PMOS does not look identical in every person, so care shouldn't be one size fits all either.

One thing we hope changes with PMOS, we hope people stop hearing:

“You just need to lose weight.”

“It's only your ovaries.”

“You only need to worry about it when you want children.”

“You don't have cysts, so you can't have PCOS.”

“Your periods aren't that important.”

Because this condition has never been just one thing.

It isn't simply an ovarian condition.

It isn't simply a fertility condition.

It isn't simply a period condition.

It isn't simply a weight condition.

And it certainly isn't simply about “cysts.”

PMOS acknowledges something Warriors have been trying to explain for years:

This condition can affect the whole person/body.

PCOS didn't suddenly become PMOS because the condition changed.

The name changed because our understanding finally caught up.

For decades, people living with this condition have dealt with misconceptions, delayed diagnoses, stigma and healthcare that sometimes focused on one piece of an incredibly complicated puzzle. Changing four words won't fix every one of those problems.

But words shape awareness.

Awareness shapes research.

Awareness shapes conversations in doctors' rooms.

Awareness can influence diagnosis, funding, education and ultimately the standard of care people receive. So while changing PCOS to PMOS might look small written on a page, what it represents is anything but small.

It says:

This is more than cysts.

This is more than ovaries.

This is more than fertility.

And the millions of Warriors living with it deserve healthcare that recognises the complete picture.

At The Endo Essentials, we'll begin transitioning our education and awareness from PCOS to PMOS (formerly PCOS) too while continuing to use both terms where necessary so that Warriors searching for information under the name they've known for years can still find the support and community they're looking for.

Because whether you know it as PCOS, PMOS or you're still getting used to the change, one thing hasn't changed:

Your symptoms deserve to be heard. Your health deserves to be taken seriously. And you deserve to understand what is happening in your own body.

Sources & Further Reading:

The information in this article has been compiled using current international evidence, clinical guidance and official information regarding the 2026 transition from Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS).

• Monash University: International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome: PMOS Terminology Update, 2026
https://www.monash.edu/medicine/mchri/pcos/guideline

• The Lancet: Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process, 2026
https://doi.org/10.1016/S0140-6736(26)00717-8

• Endocrine Society: PCOS renamed PMOS to better reflect complex hormonal and metabolic condition, 2026
https://www.endocrine.org/news-and-advocacy/news-room/2026/pcos-name-change

• American Society for Reproductive Medicine (ASRM): PCOS is now PMOS: Understanding the Name Change, 2026
https://www.asrm.org/news-and-events/asrm-news/latest-news/may-27-2026-pcos-is-now-pmos-understanding-the-name-change/

Medical Disclaimer:

The Endo Essentials is a lived experience community and awareness platform. We are not doctors or a substitute for professional medical advice, diagnosis or treatment.

This article is provided for general education and awareness and reflects information available at the time of publication. If you have questions about PMOS, symptoms you are experiencing, an existing PCOS diagnosis or your treatment, please speak with your GP or an appropriately qualified healthcare professional.

If you are experiencing a medical emergency or have serious concerns about your health, please seek urgent medical assistance or attend your nearest emergency department.